| Role of chronic neuroinflammation in neuroplasticity and cognitive function: A hypothesis D Lecca, YJ Jung, MT Scerba, I Hwang, YK Kim, S Kim, S Modrow, ... Alzheimer's & Dementia 18 (11), 2327-2340, 2022 | 85 | 2022 |
| Glucagon-like peptide-1 (GLP-1) receptor agonists and neuroinflammation: Implications for neurodegenerative disease treatment KO Kopp, EJ Glotfelty, Y Li, NH Greig Pharmacological research 186, 106550, 2022 | 64 | 2022 |
| Post-treatment with PT302, a long-acting Exendin-4 sustained release formulation, reduces dopaminergic neurodegeneration in a 6-Hydroxydopamine rat model of Parkinson’s disease S Chen, SJ Yu, Y Li, D Lecca, E Glotfelty, HK Kim, HI Choi, BJ Hoffer, ... Scientific Reports 8 (1), 10722, 2018 | 58 | 2018 |
| Glucagon-like peptide-1 (GLP-1)-based receptor agonists as a treatment for Parkinson’s disease EJ Glotfelty, L Olson, TE Karlsson, Y Li, NH Greig Expert opinion on investigational drugs 29 (6), 595-602, 2020 | 54 | 2020 |
| Structural, morphological, and functional correlates of corneal endothelial toxicity following corneal exposure to sulfur mustard vapor P McNutt, K Tuznik, M Nelson, A Adkins, M Lyman, E Glotfelty, J Hughes, ... Investigative ophthalmology & visual science 54 (10), 6735-6744, 2013 | 37 | 2013 |
| Incretin mimetics as rational candidates for the treatment of traumatic brain injury EJ Glotfelty, TE Delgado, LB Tovar-y-Romo, Y Luo, BJ Hoffer, L Olson, ... ACS pharmacology & translational science 2 (2), 66-91, 2019 | 35 | 2019 |
| Engineering botulinum neurotoxin C1 as a molecular vehicle for intra-neuronal drug delivery EJ Vazquez-Cintron, PH Beske, L Tenezaca, BQ Tran, JM Oyler, ... Scientific reports 7 (1), 42923, 2017 | 31 | 2017 |
| Pharmacokinetics and efficacy of PT302, a sustained-release Exenatide formulation, in a murine model of mild traumatic brain injury M Bader, Y Li, D Lecca, V Rubovitch, D Tweedie, E Glotfelty, L Rachmany, ... Neurobiology of disease 124, 439-453, 2019 | 29 | 2019 |
| Botulinum and tetanus neurotoxin-induced blockade of synaptic transmission in networked cultures of human and rodent neurons PH Beske, AB Bradford, JO Grynovicki, EJ Glotfelty, KM Hoffman, ... Toxicological Sciences 149 (2), 503-515, 2016 | 29 | 2016 |
| The metabolite GLP‐1 (9‐36) is neuroprotective and anti‐inflammatory in cellular models of neurodegeneration Y Li, EJ Glotfelty, TE Karlsson, LV Fortuno, BK Harvey, NH Greig Journal of Neurochemistry 159 (5), 867-886, 2021 | 26 | 2021 |
| Neuronal delivery of antibodies has therapeutic effects in animal models of botulism PM McNutt, EJ Vazquez-Cintron, L Tenezaca, CA Ondeck, KE Kelly, ... Science translational medicine 13 (575), eabd7789, 2021 | 26 | 2021 |
| Neurotrophic and neuroprotective effects of a monomeric GLP-1/GIP/Gcg receptor triagonist in cellular and rodent models of mild traumatic brain injury Y Li, EJ Glotfelty, I Namdar, D Tweedie, L Olson, BJ Hoffer, RD DiMarchi, ... Experimental neurology 324, 113113, 2020 | 23 | 2020 |
| PT320, sustained-release exendin-4, mitigates L-DOPA-induced dyskinesia in a rat 6-hydroxydopamine model of Parkinson’s disease SJ Yu, S Chen, YY Yang, EJ Glotfelty, J Jung, HK Kim, HI Choi, DS Choi, ... Frontiers in Neuroscience 14, 785, 2020 | 18 | 2020 |
| Contributions of tissue‐specific pathologies to corneal injuries following exposure to SM vapor PM McNutt, KM Tuznik, EJ Glotfelty, MR Nelson, ME Lyman, TA Hamilton Annals of the New York Academy of Sciences 1374 (1), 132-143, 2016 | 15 | 2016 |
| The RhoA-ROCK1/ROCK2 pathway exacerbates inflammatory signaling in immortalized and primary microglia EJ Glotfelty, LB Tovar-y-Romo, SC Hsueh, D Tweedie, Y Li, BK Harvey, ... Cells 12 (10), 1367, 2023 | 14 | 2023 |
| (−)‐Phenserine tartrate (PhenT) as a treatment for traumatic brain injury NH Greig, D Lecca, SC Hsueh, C Nogueras‐Ortiz, D Kapogiannis, ... CNS Neuroscience & Therapeutics, 2019 | 13 | 2019 |
| " No Other Choice": A Baseline Study on the Vulnerabilities of Males in the Sex Trade in Chiang Mai, Thailand JD Davis, E Glotfelty, G Miles Dignity: A Journal of Analysis of Exploitation and Violence 2 (4), 10, 2017 | 11 | 2017 |
| A new generation of imids as treatments for neuroinflammatory and neurodegenerative disorders KO Kopp, ME Greer, EJ Glotfelty, SC Hsueh, D Tweedie, DS Kim, M Reale, ... Biomolecules 13 (5), 747, 2023 | 6 | 2023 |
| BOYS FOR BAHT ? An exploratory study on the vulnerability of male entertainment workers in Chiang Mai, Thailand J Davis, E Glotfelty, G Miles Love146, 2013 | 5 | 2013 |
| Psilocybin combines rapid synaptogenic and anti-inflammatory effects in vitro G Smedfors, E Glotfelty, N Kalani, CP Hjelle, O Horntvedt, K Wellfelt, ... | 3 | 2022 |
NIGEL GREIGChief, Drug Design & Development Section, National Institute on Aging, NIH在 grc.nia.nih.gov 的电子邮件经过验证
